Aberrant activation of TRIP13-EZH2 signaling axis promotes

€ 23.99

4.6
(696)
Auf Lager
Beschreibung

Activation of AKT induces EZH2-mediated β-catenin trimethylation in colorectal cancer - ScienceDirect

Activation of AKT induces EZH2-mediated β-catenin trimethylation in colorectal cancer

DCZ0415, a small‐molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β‐catenin pathway in colorectal cancer - Agarwal - 2022 - Molecular Oncology - Wiley

Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data

TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching

Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer - Gastroenterology

The interplay of long noncoding RNAs and hepatitis B virus - Sarfaraz - 2023 - Journal of Medical Virology - Wiley Online Library

Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics

TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching